Dr. Joseph Mercola: The Misinformation ‘Superspreader’
A new documentary from The New York Times explores the contentious career and business of the Florida-based physician.
A new documentary from The New York Times explores the contentious career and business of the Florida-based physician.
The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.
The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.
The BA.5 surge is a reminder that we need to take precautions to avoid illness, slow the relentless cycle of new variants and minimize the […]
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
El aumento de la subvariante BA.5 es un recordatorio de que debemos tomar precauciones para evitar enfermarnos, desacelerar el ciclo implacable de nuevas variantes y […]
El aumento de la subvariante BA.5 es un recordatorio de que debemos tomar precauciones para evitar enfermarnos, desacelerar el ciclo implacable de nuevas variantes y […]
El aumento de la subvariante BA.5 es un recordatorio de que debemos tomar precauciones para evitar enfermarnos, desacelerar el ciclo implacable de nuevas variantes y […]
The BA.5 surge is a reminder that we need to take precautions to avoid illness, slow the relentless cycle of new variants and minimize the […]
Long lines for vaccines. Testing is slowed. Antivirals are held up. Treatment is easier for the privileged. Sound familiar?
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Members of the global trade group were forced to scale back plans for more ambitious agreements, but they were ultimately able to reach several deals […]
Members of the global trade group were forced to scale back plans for more ambitious agreements, but they were ultimately able to reach several deals […]
Members of the global trade group were forced to scale back plans for more ambitious agreements, but they were ultimately able to reach several deals […]
The Food and Drug Administration authorized both the Moderna and Pfizer-BioNTech coronavirus vaccines for use in children as young as six months. Doses would be […]
Members of the global trade group were forced to scale back plans for more ambitious agreements, but they were ultimately able to reach several deals […]
As eagerly anticipated as the shots are for some parents, the F.D.A. advisory committee’s decisions are just one step in a process federal regulators must […]
As eagerly anticipated as the shots are for some parents, the committee’s meeting is just one step in a process federal regulators must follow before […]
Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest […]
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
The report sheds new light on executives’ worries about deficiencies in the company’s quality control systems at its troubled Baltimore plant; no contaminated doses were […]
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
And information about antivirals, from Times reporters and readers.
And information about antivirals, from Times reporters and readers.
Once again, a dysfunctional health care system has hindered our pandemic response.
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
Readers discuss moves to ban abortion pills and lament passage of an Oklahoma anti-abortion bill. Also: Saving baseball; sex and manners; Covid vaccines.
Tomar estas siete medidas ahora puede reducir tu riesgo y minimizar la perturbación en la vida de tu familia.
Taking these seven steps now can lower your risk and minimize the disruption to your family’s life.
People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune […]
The plan will offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again […]
The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic […]
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for […]
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for […]
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for […]
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for […]
Beijing once said it had two mRNA shots within reach and ready for approval — one homemade and one produced by a foreign company. Today, […]
El país había dicho que tenía dos vacunas con esta tecnología a su alcance y listas para ser aprobadas: una nacional y otra producida por […]
El país había dicho que tenía dos vacunas con esta tecnología a su alcance y listas para ser aprobadas: una nacional y otra producida por […]
El país había dicho que tenía dos vacunas con esta tecnología a su alcance y listas para ser aprobadas: una nacional y otra producida por […]
Beijing once said it had two mRNA shots within reach and ready for approval — one homemade and one produced by a foreign company. Today, […]
Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del […]
Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del […]
There has to be a better way out of the rubble of the past two years.
There has to be a better way out of the rubble of the past two years.
Pharmacists and technicians, who have played a critical role in administering Covid-19 tests and vaccines, say they are burned out nearly two years into the […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
Myocarditis, or inflammation of the heart muscle, occurred in 1 of 12,361 boys between 12 and 15 years old within a week of receiving a […]
Karen S. Lynch, who took over during the pandemic, is dealing with insurance, opioids, vaccines, politics and more.
Following the F.D.A.’s lead, the agency also recommended third shots after four weeks for some immunocompromised children 5 to 11.
Following the F.D.A.’s lead, the agency also recommended third shots after four weeks for some immunocompromised children 5 to 11.
Regulators will also allow even younger children with immune deficiencies to get an extra shot.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
The vaccine will be the fifth to become available in the E.U., which already has ample supplies.
The vaccine will be the fifth to become available in the E.U., which already has ample supplies.
The vaccine will be the fifth to become available in the E.U., which already has ample supplies.
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
Vaccine shortages and skepticism, and rewarding countries for discovering variants. Also: Happiness and politics; unwanted children; beware of psychedelics.
Vaccine shortages and skepticism, and rewarding countries for discovering variants. Also: Happiness and politics; unwanted children; beware of psychedelics.
Spain surpassed others in Europe by avoiding politicized debate about Covid shots. Citizens also largely heeded the health guidance from their leaders.
Spain surpassed others in Europe by avoiding politicized debate about Covid shots. Citizens also largely heeded the health guidance from their leaders.
Spain surpassed others in Europe by avoiding politicized debate about Covid shots. Citizens also largely heeded the health guidance from their leaders.
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
The move adds more than 2.8 million young people to those eligible for a shot.
The move adds more than 2.8 million young people to those eligible for a shot.
The move adds more than 2.8 million young people to those eligible for a shot.
The move adds more than 2.8 million young people to those eligible for a shot.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The move adds more than 2.8 million young people to those eligible for a shot.
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
Regulators are set to clear extra doses of Pfizer-BioNTech’s vaccine as soon as Thursday, after states began expanding eligibility on their own.
Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.
Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.
Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.
Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
Moderna’s patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.
Moderna’s patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current […]
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es […]
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es […]
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
Once the experts weigh in, the Food and Drug Administration itself makes a decision and then a similar process happens at the Centers for Disease […]
Pfizer and Moderna are skeptical, but we found 10 companies in Africa, Asia and South America well-positioned to produce the gold-standard mRNA shots.
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps next week, a long-awaited development that would affect 28 million children.
Pfizer and Moderna are skeptical, but we found 10 companies in Africa, Asia and South America well-positioned to produce the gold-standard mRNA shots.
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.
Experts strongly agree that the shots benefit the mother as well as the fetus.
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
The agency will also allow vaccine recipients to pick which vaccine they want as a booster, endorsing a mix-and-match approach.
The agency will also allow vaccine recipients to pick which vaccine they want as a booster, endorsing a mix-and-match approach.
The defense ministry said there was too little demand for its Fakhravac vaccine to justify producing it, and blamed the health ministry for reneging on […]
Experts strongly agree that the shots benefit the mother as well as the fetus.
Experts strongly agree that the shots benefit the mother as well as the fetus.
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines voted on this week? This scorecard may […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines voted on this week? This scorecard may […]
Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
The experts’ recommendations, though not binding, are likely to influence what the Food and Drug Administration decides on whether to authorize the boosters.
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
Moderna sells its vaccine almost exclusively to wealthy countries.
Moderna sells its vaccine almost exclusively to wealthy countries.
Moderna sells its vaccine almost exclusively to wealthy countries.
Moderna sells its vaccine almost exclusively to wealthy countries.
Moderna sells its vaccine almost exclusively to wealthy countries.
The company is seeking authorization for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be eligible.
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The agency has promised to move quickly on the request and has tentatively scheduled a meeting at the end of the month to consider it.
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as […]
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The E.U.’s main drug regulator also said that extra doses of the Moderna and Pfizer-BioNTech vaccines can be given to those with underlying health conditions […]
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
President Biden’s Covid adviser also says it is “too soon to tell” if the Delta surge will decline enough to allow safe gatherings around the […]
Readers discuss the government’s handling of the issue. Also: Abortion stories; criminal justice reform; voice recognition; extinct species.
El mundo agropecuario lucha contra la creciente demanda de ivermectina, un medicamento antiparasitario que las redes de desinformación aseguran, sin pruebas, que ayuda contra el […]
The finding came from a study of Americans who got their third vaccine dose in August and September, and provided a reassuring sign about the […]
The poll also found that many of the unvaccinated believe that a push for booster shots shows that the inoculations are not working.
Veterinarians, ranchers and farmers say they are struggling with the effects of the surging demand for ivermectin, a deworming drug.
Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision […]
Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision […]
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The F.D.A. needs a new system for responding to pandemics.
The F.D.A. needs a new system for responding to pandemics.
The F.D.A. needs a new system for responding to pandemics.
Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses […]
Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses […]
Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses […]
Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses […]
Dozens of human rights and other advocacy groups urge President Biden to back a $25 billion investment that would produce 8 billion Covid-19 vaccine doses […]
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
The study came out hours before an expert panel of advisers to the F.D.A. voted not to recommend booster shots.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Federal health officials released a handful of studies highlighting how effective the shots are at preventing infections, hospitalizations and deaths — even while the highly […]
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series […]
“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series […]
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
As children’s hospital beds fill up, the F.D.A. shouldn’t delay.
As children’s hospital beds fill up, the F.D.A. shouldn’t delay.
A lack of systematic evidence has kept scientists one step behind in the pandemic.
Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on […]
Copyright © 2024 | WordPress Theme by MH Themes